Related Experiment Videos

[Lipoprotein(a) and other lipid parameters in cord blood: a study of 528 cases]

J C Vella1, P Calmarza

  • 1Hospital General Yagüe, Burgos, Espagne.

Insights

Lipoprotein (a) levels in newborn cord blood may indicate future cardiovascular disease risk. Higher levels in infants with a family history of heart disease suggest lipoprotein (a) is a significant risk factor.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Cardiovascular Medicine

Context:

  • Cord blood lipid profiles offer early insights into neonatal health.
  • Understanding neonatal lipid parameters is crucial for predicting long-term health outcomes.
  • This study examines key lipid and apolipoprotein concentrations in a specific neonatal cohort.

Purpose:

  • To analyze concentrations of cholesterol, triglycerides, HDL cholesterol, apolipoproteins A-I and B, and lipoprotein (a) in cord blood.
  • To compare these neonatal lipid values with existing population data.
  • To investigate the association between familial history of cardiovascular heart disease and neonatal lipoprotein (a) levels.

Summary:

  • Cholesterol and triglyceride levels in the studied cord blood were slightly lower than in other populations.
  • Lipoprotein (a) concentrations showed a distribution skewed towards lower values, consistent with Caucasian populations.
  • Infants with a positive family history of cardiovascular heart disease exhibited higher mean lipoprotein (a) levels and a greater prevalence of elevated values (>5 mg/dl).

Impact:

  • The findings highlight lipoprotein (a) as a potential early indicator and significant risk factor for cardiovascular heart disease.
  • This research underscores the importance of neonatal screening for lipid profiles, particularly lipoprotein (a).
  • Results contribute to understanding the genetic and familial influences on cardiovascular risk from birth.

Related Concept Videos